Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Allogene Therapeutics Inc (ALLO)
NASDAQ:ALLO
Holding ALLO?
Track your performance easily
See the Price Targets and Ratings of:
ALLO Analyst Ratings
Strong Buy
8 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ALLO Stock 12 Month Forecast
Average Price Target
$9.79
▲(381.08% Upside)
| Highest Price Target$14.00 | Average Price Target$9.79 | Lowest Price Target$4.50 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
JMP Securities
Reiterated
11/20/24
Piper Sandler
Assigned
11/14/24
William Blair
Reiterated
11/14/24
TD Cowen
Assigned
11/11/24
Stifel Nicolaus
Reiterated
11/11/24
Oppenheimer
Reiterated
11/08/24
Robert W. Baird
Reiterated
11/08/24
H.C. Wainwright
Reiterated
11/08/24
Canaccord Genuity
Reiterated
11/07/24
RBC Capital
Reiterated
11/07/24
Truist Financial
$17→$14
Buy
587.96%
Upside
Reiterated
08/09/24
Analysts Offer Insights on Healthcare Companies: Indivior (LSE: GB:INDV), Vor Biopharma (NASDAQ: VOR) and Allogene Therapeutics (NASDAQ: ALLO)
Citi
$7→$8
Buy
293.12%
Upside
Assigned
08/09/24
Allogene Therapeutics price target raised to $8 from $7 at CitiAllogene Therapeutics price target raised to $8 from $7 at Citi
B.Riley Financial
$10→$7
Buy
243.98%
Upside
Reiterated
05/14/24
Allogene (ALLO) PT Lowered to $7 at B.RileyB.Riley analyst Kalpit Patel lowered the price target on Allogene (NASDAQ: ALLO) to $7.00 (from $10.00) while maintaining a Buy rating.
J.P. Morgan
$9→$8
Buy
293.12%
Upside
Reiterated
02/27/24
Allogene (ALLO) PT Lowered to $8 at JPMorganJPMorgan analyst Brian Cheng lowered the price target on Allogene (NASDAQ: ALLO) to $8.00 (from $9.00) while maintaining a Overweight rating.
Best Analysts Covering Allogene Therapeutics
Which Analyst Should I Follow If I Want to Buy ALLO and Sell After:
1 Month
xxx
Success Rate
5/13 ratings generated profit
Average Return
-5.55%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 38.46% of your transactions generating a profit, with an average return of -5.55% per trade.
3 Months
xxx
Success Rate
8/19 ratings generated profit
Average Return
+2.37%
reiterated a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 42.11% of your transactions generating a profit, with an average return of +2.37% per trade.
1 Year
Success Rate
4/19 ratings generated profit
Average Return
-24.54%
reiterated a buy rating 15 days ago
Copying John Newman's trades and holding each position for 1 Year would result in 21.05% of your transactions generating a profit, with an average return of -24.54% per trade.
2 Years
xxx
Success Rate
2/12 ratings generated profit
Average Return
-37.48%
assigned a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 16.67% of your transactions generating a profit, with an average return of -37.48% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ALLO Analyst Recommendation Trends
Rating
Jun 24
Jul 24
Aug 24
Oct 24
Nov 24
Strong Buy
9
9
11
11
16
Buy
3
4
3
3
5
Hold
2
2
2
2
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
14
15
16
16
26
Each month's total comprises the sum of three months' worth of ratings.
ALLO Financial Forecast
ALLO Stock Forecast FAQ
What is ALLO’s average 12-month price target, according to analysts?
Based on analyst ratings, Allogene Therapeutics Inc’s 12-month average price target is $9.79.
What is ALLO’s upside potential, based on the analysts’ average price target?
Allogene Therapeutics Inc has 381.08% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ALLO a Buy, Sell or Hold?
Allogene Therapeutics Inc has a consensus rating of Strong Buy which is based on 8 buy ratings, 2 hold ratings and 0 sell ratings.
What is Allogene Therapeutics Inc’s price target?
The average price target for Allogene Therapeutics Inc is $9.79. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $14.00 ,the lowest forecast is $4.50. The average price target represents 381.08% Increase from the current price of $2.035.
The highest analyst price target is $14.00 ,the lowest forecast is $4.50. The average price target represents 381.08% Increase from the current price of $2.035.
What do analysts say about Allogene Therapeutics Inc?
Allogene Therapeutics Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of ALLO?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.